Skip Navigation

European Heart Journal 1988 9(11):1194-1199;
Copyright © 1988 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by VAN DUK, R.B.
Right arrow Articles by CRUNS, H.J.G.M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VAN DUK, R.B.
Right arrow Articles by CRUNS, H.J.G.M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 The European Society of Cardiology

Dilitiazem in Comparison with metoprolol in stable angina pectoris

R.B. VAN DUK, K.I. LIE and H.J.G.M CRUNS

Department of Cadiology(Thoraxcentre),University Hospital Groningen Oostersingel 59,9713 EZ Groningen,The Netherlands

Received 7 October 1987; revised 5 April 1988; .

René B. van Dijk, Thoraxcentre, University Hospital Groningen, Oostersingel 59, 9713 EZ Groningen. The Netherlands.

Abstract

The efficacy of diltiazem in comparison with metoprolol in chornic stable angina was asessted in 33 male patients during a 15-week blind cross-over study. After an initial two-week run-in period, baseline measuremens were made. Subsequently,the patients enered a cross-over study consisting of two six-week treatment periods with diltiazem 240 mg (60 mg q.i.d.)or metoprol 200 mg (100 mg b.i.d.).Dose adjustment to either 360 mg diltiazem(120t.i.d.)or 400 mg metoprolol(200b.i.d.)was allowed two weeks after the start of treatment. There was a one-week washout period between the two treatment periods.

Compared to baseline values both drugs reduced the number of anginal attacks (diltiazem –55%,p=0.02; metoprolol –73%,P=0.01)and showed improvement of the measured exercise variables(exercise duration; diltiazem +16%,P<0.001;meoprolol +4%,P=NS; time to angina:diltiazem +21%,P=0.02,metoprolol + 14%, P =NS;maximal ST-depression: diltiazem +13%,P =NS,metoprolol +33%,P=0.002).No significant change in LVEF was noticed.Both drugs reduced the mean heart rate on Holter tape (diltiazem–11%,P=0.006;metoprolol –14%, P=0.004). No effects on conduction were noticed.

Although at the borderline of significance, diltiazem increased the total exercise duration as compared to metoprolol (16 vs, 4%,P=0.05). It is concluded that diltiazem improves exercise tolerance in patients with stable angina pectoris and appears to be a safe and effective alternative to the beta-blocking agent metoprolol.Our findings underscore the value of diltiazem as a monotherapeutic drug for the treatment of stable angina.

Key Words: Angina pectoris, • diltiazem, • metoprolol, • calcium antagonists, • beta blockers.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197.
[Full Text] [PDF]


Home page
JAMAHome page
P. A. Heidenreich, K. M. McDonald, T. Hastie, B. Fadel, V. Hagan, B. K. Lee, and M. A. Hlatky
Meta-analysis of Trials Comparing {beta}-Blockers, Calcium Antagonists, and Nitrates for Stable Angina
JAMA, May 26, 1999; 281(20): 1927 - 1936.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.